TY - JOUR
T1 - Cardiac Complications in Patients Hospitalised With COVID-19 in Australia
AU - Bhatia, Kunwardeep S
AU - Sritharan, Hari P
AU - Chia, Justin
AU - Ciofani, Jonathan
AU - Nour, Daniel
AU - Chui, Karina
AU - Vasanthakumar, Sheran
AU - Jayadeva, Pavithra
AU - Kandadai, Dhanvee
AU - Allahwala, Usaid
AU - Bhagwandeen, Rohan
AU - Brieger, David B
AU - Choong, Christopher Y P
AU - Delaney, Anthony
AU - Dwivedi, Girish
AU - Harris, Benjamin
AU - Hillis, Graham
AU - Hudson, Bernard
AU - Javorsky, George
AU - Jepson, Nigel
AU - Kanagaratnam, Logan
AU - Kotsiou, George
AU - Lee, Astin
AU - Lo, Sidney T H
AU - MacIsaac, Andrew I
AU - McQuillan, Brendan M
AU - Ranasinghe, Isuru
AU - Walton, Antony
AU - Weaver, James
AU - Wilson, William
AU - Yong, Andy
AU - Zhu, John
AU - van Gaal, William
AU - Kritharides, Leonard
AU - Chow, Clara
AU - Bhindi, Ravinay
N1 - Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.
PY - 2021/12
Y1 - 2021/12
N2 - OBJECTIVES: Describe the incidence of cardiac complications in patients admitted to hospital with COVID-19 in Australia.DESIGN: Observational cohort study.SETTING: Twenty-one (21) Australian hospitals.PARTICIPANTS: Consecutive patients aged ≥18 years admitted to hospital with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.MAIN OUTCOME MEASURES: Incidence of cardiac complications.RESULTS: Six-hundred-and-forty-four (644) hospitalised patients (62.5±20.1 yo, 51.1% male) with COVID-19 were enrolled in the study. Overall in-hospital mortality was 14.3%. Twenty (20) (3.6%) patients developed new atrial fibrillation or flutter during admission and 9 (1.6%) patients were diagnosed with new heart failure or cardiomyopathy. Three (3) (0.5%) patients developed high grade atrioventricular (AV) block. Two (2) (0.3%) patients were clinically diagnosed with pericarditis or myopericarditis. Among the 295 (45.8%) patients with at least one troponin measurement, 99 (33.6%) had a peak troponin above the upper limit of normal (ULN). In-hospital mortality was higher in patients with raised troponin (32.3% vs 6.1%, p<0.001). New onset atrial fibrillation or flutter (6.4% vs 1.0%, p=0.001) and troponin elevation above the ULN (50.3% vs 16.4%, p<0.001) were more common in patients 65 years and older. There was no significant difference in the rate of cardiac complications between males and females.CONCLUSIONS: Among patients with COVID-19 requiring hospitalisation in Australia, troponin elevation was common but clinical cardiac sequelae were uncommon. The incidence of atrial arrhythmias and troponin elevation was greatest in patients 65 years and older.
AB - OBJECTIVES: Describe the incidence of cardiac complications in patients admitted to hospital with COVID-19 in Australia.DESIGN: Observational cohort study.SETTING: Twenty-one (21) Australian hospitals.PARTICIPANTS: Consecutive patients aged ≥18 years admitted to hospital with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.MAIN OUTCOME MEASURES: Incidence of cardiac complications.RESULTS: Six-hundred-and-forty-four (644) hospitalised patients (62.5±20.1 yo, 51.1% male) with COVID-19 were enrolled in the study. Overall in-hospital mortality was 14.3%. Twenty (20) (3.6%) patients developed new atrial fibrillation or flutter during admission and 9 (1.6%) patients were diagnosed with new heart failure or cardiomyopathy. Three (3) (0.5%) patients developed high grade atrioventricular (AV) block. Two (2) (0.3%) patients were clinically diagnosed with pericarditis or myopericarditis. Among the 295 (45.8%) patients with at least one troponin measurement, 99 (33.6%) had a peak troponin above the upper limit of normal (ULN). In-hospital mortality was higher in patients with raised troponin (32.3% vs 6.1%, p<0.001). New onset atrial fibrillation or flutter (6.4% vs 1.0%, p=0.001) and troponin elevation above the ULN (50.3% vs 16.4%, p<0.001) were more common in patients 65 years and older. There was no significant difference in the rate of cardiac complications between males and females.CONCLUSIONS: Among patients with COVID-19 requiring hospitalisation in Australia, troponin elevation was common but clinical cardiac sequelae were uncommon. The incidence of atrial arrhythmias and troponin elevation was greatest in patients 65 years and older.
U2 - 10.1016/j.hlc.2021.08.001
DO - 10.1016/j.hlc.2021.08.001
M3 - Article
C2 - 34481762
SN - 1444-2892
VL - 30
SP - 1834
EP - 1840
JO - Heart, Lung & Circulation
JF - Heart, Lung & Circulation
IS - 12
ER -